HBA Cambridge, in collaboration with Deloitte, invites you to an engaging panel discussion exploring how a prevention-first approach can transform healthcare outcomes and create a more sustainable future for health systems worldwide.
Drawing on insights from the Deloitte's landmark 2025 report, The Shift to Prevention: A New Ecosystem of Health Promotion and Protection, our expert panel will examine the evidence, economics, and practical actions needed to move from a treatment-focused model of care to one centred on prevention, early intervention, and long-term wellbeing. The discussion will also highlight the critical role of the patient perspective in shaping effective prevention strategies and ensuring that healthcare solutions meet the real needs of the people they are designed to serve.
By attending the Pioneering Prevention for a Healthier Future event – you will:
Discover why investing in prevention across the life course is one of the most powerful opportunities to improve health outcomes and healthcare sustainability.
Explore the partnerships, policies, and innovations required to build a stronger prevention ecosystem.
Hear expert perspectives on how employers, healthcare providers, policymakers, innovators, and patients can work together to reduce the burden of preventable disease.
Gain insights into how the patient voice can help shape more effective, equitable, and accessible approaches to prevention.
Connect with professionals committed to advancing health, prevention, and wellbeing across the Cambridge life sciences and healthcare community.
Learn more about the HBA’s mission and its commitment to driving meaningful change.
The event is hosted by Deloitte at the Deloitte Offices, 1 Station Square, Cambridge, CB1 2GA.
Elizabeth Hampson (Deloitte) will chair the panel discussion, featuring Carina Kern (Chief Executive Officer of LinkGevity), Dr Juliet Usher-Smith (Academic GP, Head of the Primary Care Unit within the Department of Public Health and Primary Care at the University of Cambridge), Tim Bennet (Director, UK & Ireland Government Affairs at Illumina), Professor Simon Kenny (National Clinical Director - Children and Young People) and Rachael Griffin (Jazz Pharma , HBA Cambridge member and breast cancer patient advocate).